ZDHHC12 and central nervous system cancer: zDHHC12 is also aberrantly expressed in gliomas, and knockdown of zDHHC12 reduces glioma cell survival, while overexpression of zDHHC12 not only promotes glioma cell growth but is also associated with immune cell infiltration (Lu et al., 2022).